Thomas A. Davis

Thomas A. Davis, PhD is a Professor and Vice Chair of Research in the Department of Surgery at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine. With over 45 years of research experience, Dr. Davis leads trauma and regenerative medicine research initiatives focused on military medical applications. His work bridges basic science with clinical translation to address combat-related injuries.

Dr. Davis received his educational training at:

• PhD in Immunology from George Washington University (1993)
• M.S. in Immunology and Microbiology from George Mason University (1987)
• B.S. in Biology from George Mason University (1983)

Dr. Davis's research centers on understanding the mechanisms of acute cellular and organ injury in inflammatory states such as shock, trauma, and sepsis. His laboratory investigates two primary areas: the innate immune response to traumatic injury, with emphasis on damage associated molecular pattern molecules (DAMPs) and pattern recognition receptors (PRR), and the development of regenerative tissue approaches for musculoskeletal trauma. His work employs diverse models including blast injury, hemorrhagic shock, burn injury, and severe musculoskeletal tissue loss.

Analysis of Dr. Davis's recent publications reveals a strong focus on combat-related trauma, particularly blast injuries and their complications. His research integrates molecular biology, immunology, and tissue engineering to address military-relevant medical challenges. Key themes include heterotopic ossification following blast injuries, neuroinflammatory responses to trauma, and the development of combat-applicable trauma models.

Dr. Davis has received prestigious recognition for his contributions to military medicine:

• 2023 USUHS School of Medicine Impact Award
• 2023 Military Health System Research Symposium's (MHSRS) Distinguished Service Award

As Vice Chair of Research, Dr. Davis oversees multiple funded projects supported by the Department of Defense. His research portfolio includes development of combat-applicable lower extremity trauma models and early diagnosis strategies for post-traumatic heterotopic ossification. He serves on committees including the MCB Qualifying Exam Committee and as an MHSRS Abstract Reviewer, mentoring the next generation of military medical researchers.

Dr. Davis leads a research team focused on advancing regenerative medicine approaches for traumatic injuries. His laboratory develops innovative cell-based therapies for conditions like heterotopic ossification and critical tissue loss, with emphasis on establishing new methods for measuring stem and progenitor cells to advance cell and gene therapy applications.